Cetera Investment Advisers
ELDN icon

Cetera Investment Advisers’s Eledon Pharmaceuticals ELDN Stock Holding History

Cetera Investment Advisers’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Buy
28,867
+520
+2% +$1.89K ﹤0.01% 4644
2026
Q1 		$87.3K Buy
28,347
+1,763
+7% +$4.15K ﹤0.01% 4489
2025
Q4 		$40.1K Buy
26,584
+11,207
+73% +$26.6K ﹤0.01% 4533
2025
Q3 		$39.8K Buy
+15,377
New +$45K ﹤0.01% 4450

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Cetera Investment Advisers's ELDN Position: Q2 2026 in Review

Cetera Investment Advisers increased its Eledon Pharmaceuticals (ELDN) stake by 1.8% in Q2 2026, buying an estimated $1.89K and bringing the position to 28,867 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #4644.

Cetera Investment Advisers first reported a position in ELDN in Q3 2025 and has held it in 4 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Cetera Investment Advisers held 28,867 shares of Eledon Pharmaceuticals worth $114K as of Q2 2026.
  • Cetera Investment Advisers bought 520 Eledon Pharmaceuticals shares in Q2 2026, an estimated $1.89K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4644 holding.
  • Cetera Investment Advisers first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.